215 related articles for article (PubMed ID: 35657479)
1. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study.
Tan N; Ngu N; Worland T; Lee T; Abrahams T; Pandya K; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson A; Ding J; Nicoll AJ; Liu K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A;
Hepatol Int; 2022 Oct; 16(5):1094-1104. PubMed ID: 35657479
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of primary sclerosing cholangitis: an Australian non-transplant tertiary hospital perspective.
Freeman E; Majeed A; Kemp W; Roberts SK
Intern Med J; 2019 Mar; 49(3):323-327. PubMed ID: 30043518
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
[TBL] [Abstract][Full Text] [Related]
5. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
6. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.
Liu K; Wang R; Kariyawasam V; Wells M; Strasser SI; McCaughan G; Corte C; Leong RW
Liver Int; 2017 Mar; 37(3):442-448. PubMed ID: 27891750
[TBL] [Abstract][Full Text] [Related]
8. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
[TBL] [Abstract][Full Text] [Related]
10. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma in primary sclerosing cholangitis.
Abbas G; Lindor KD
J Gastrointest Cancer; 2009; 40(1-2):19-25. PubMed ID: 19705300
[TBL] [Abstract][Full Text] [Related]
14. Outruling cholangiocarcinoma in patients with primary sclerosing cholangitis wait-listed for liver transplantation: A report on the Irish national experience.
Duggan WP; Brosnan C; Christodoulides N; Nolan N; Kambakamba P; Gallagher TK
Surgeon; 2023 Apr; 21(2):e83-e88. PubMed ID: 35680491
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
16. Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India.
Jadaun SS; Mehtani R; Hasnain A; Bhatia S; Moond V; Kumar M; Kuhad V; Singh S; Agarwal S; Gupta S; Saigal S
Hepatol Int; 2023 Apr; 17(2):499-506. PubMed ID: 36376772
[TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.
Liu R; Cox K; Guthery SL; Book L; Witt B; Chadwick B; Adler DG
Dig Dis Sci; 2014 Sep; 59(9):2320-4. PubMed ID: 24748183
[TBL] [Abstract][Full Text] [Related]
18. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
Ali AH; Bi Y; Machicado JD; Garg S; Lennon RJ; Zhang L; Takahashi N; Carey EJ; Lindor KD; Buness JG; Tabibian JH; Chari ST
J Gastroenterol; 2020 Nov; 55(11):1087-1097. PubMed ID: 32770464
[TBL] [Abstract][Full Text] [Related]
19. Small-duct primary sclerosing cholangitis.
Björnsson E
Curr Gastroenterol Rep; 2009 Feb; 11(1):37-41. PubMed ID: 19166657
[TBL] [Abstract][Full Text] [Related]
20. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
